• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关节炎性银屑病疾病严重程度和应答者指数的制定——OMERACT10 关节炎性银屑病特别兴趣小组的报告。

Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.

机构信息

Section of Musculoskeletal Disease, University of Leeds, Leeds, UK.

出版信息

J Rheumatol. 2011 Jul;38(7):1496-501. doi: 10.3899/jrheum.110278.

DOI:10.3899/jrheum.110278
PMID:21724722
Abstract

Work within the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) to develop and validate composite disease activity measures in PsA has progressed. At the Outcome Measures in Rheumatology Clinical Trials (OMERACT) 8 meeting, a core set of domains to be assessed in randomized controlled trials (RCT) and longitudinal observational studies (LOS) of PsA was agreed upon. At OMERACT 10, work to date regarding proposed composite responder indices was presented. Five proposed composite responder definitions for PsA were reviewed and discussed including new data from the GRACE (GRAppa Composite Exercise) study. There was agreement that the work to date was promising, and that developing composite outcome measures for use in RCT and LOS was important. Further work was required, including data on followup timepoints and less common phenotypes of PsA, to ensure that all subgroups were represented within GRACE. During discussion on the concept of composite measures for PsA, based on predominant/little/no involvement in several domains (such as skin versus joints, enthesitis, dactylitis, spondyloarthritis) it was acknowledged that a simple summative score encompassing all domains of PsA would be difficult to construct psychometrically and may not be appropriate. Ideally, any composite measure should retain the ability to differentiate between activity in individual domains, such as enthesitis or skin psoriasis, so that the influence of each can be assessed independently. Further work is required within the GRACE dataset to develop an optimal composite measure for PsA. Several proposals to date have shown preliminary validity according to the OMERACT filter.

摘要

在研究和评估银屑病关节炎(GRAPPA)小组内,已经取得了进展,制定和验证了银屑病关节炎的综合疾病活动指标。在风湿病临床研究结局测量(OMERACT)会议 8 上,同意了一套在银屑病关节炎的随机对照试验(RCT)和纵向观察研究(LOS)中需要评估的核心领域。在 OMERACT 会议 10 上,提出了关于拟议综合应答指标的最新进展。对五种拟议的银屑病关节炎综合应答定义进行了审查和讨论,包括来自 GRACE(GRAppa 综合锻炼)研究的新数据。大家一致认为,迄今为止的工作有很大的前景,制定用于 RCT 和 LOS 的综合结局指标非常重要。需要进一步开展工作,包括有关随访时间点和较少见的银屑病关节炎表型的数据,以确保在 GRACE 中代表所有亚组。在讨论银屑病关节炎的综合措施概念时,考虑到在几个领域(如皮肤与关节、附着点炎、指炎、脊柱关节炎)的主要/轻微/无参与情况,人们认识到,构建涵盖所有银屑病关节炎领域的简单综合评分在心理测量学上可能很困难,并且可能不合适。理想情况下,任何综合措施都应保留区分个别领域(如附着点炎或皮肤银屑病)活动的能力,以便能够独立评估每个领域的影响。需要在 GRACE 数据集内开展进一步的工作,为银屑病关节炎开发最佳的综合措施。迄今为止的一些建议根据 OMERACT 筛选标准显示出初步的有效性。

相似文献

1
Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.关节炎性银屑病疾病严重程度和应答者指数的制定——OMERACT10 关节炎性银屑病特别兴趣小组的报告。
J Rheumatol. 2011 Jul;38(7):1496-501. doi: 10.3899/jrheum.110278.
2
Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.加强患者参与及修订核心集的必要性——2014年OMERACT银屑病关节炎工作组报告
J Rheumatol. 2015 Nov;42(11):2198-203. doi: 10.3899/jrheum.141156. Epub 2015 May 1.
3
Psoriatic arthritis assessment tools in clinical trials.临床试验中的银屑病关节炎评估工具
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii49-54. doi: 10.1136/ard.2004.034165.
4
Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.银屑病关节炎疾病活动度及缓解指标的制定——OMERACT 11银屑病关节炎模块报告
J Rheumatol. 2014 Apr;41(4):782-91. doi: 10.3899/jrheum.131250. Epub 2014 Feb 1.
5
Composite measures in psoriatic arthritis: GRAPPA 2008.银屑病关节炎的综合指标:GRAPPA 2008.
J Rheumatol. 2010 Feb;37(2):453-61. doi: 10.3899/jrheum.090956.
6
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.银屑病关节炎随机对照试验5种候选工具的内容效度、表面效度和可行性:2017年GRAPPA年会的银屑病关节炎OMERACT核心集研讨会
J Rheumatol Suppl. 2018 Jun;94:17-25. doi: 10.3899/jrheum.180142.
7
Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response.银屑病关节炎的综合疾病活动度和反应指数:来自GRAPPA 2013会议关于疾病活动状态和反应的临界值制定的报告。
J Rheumatol. 2014 Jun;41(6):1212-7. doi: 10.3899/jrheum.140172.
8
Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.银屑病关节炎的综合指标:GRAPPA2009 年会报告。
J Rheumatol. 2011 Mar;38(3):540-5. doi: 10.3899/jrheum.101116.
9
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.银屑病关节炎结局指标的定义:GRAPPA-OMERACT工作组报告
J Rheumatol. 2017 May;44(5):697-700. doi: 10.3899/jrheum.170150.
10
A review of disease activity measures for psoriatic arthritis: what is the best approach?银屑病关节炎疾病活动度测量方法综述:最佳方法是什么?
Expert Rev Clin Immunol. 2014 Sep;10(9):1241-54. doi: 10.1586/1744666X.2014.943663. Epub 2014 Aug 4.

引用本文的文献

1
The Psoriatic Arthritis 5-Thermometer Scales (PsA-5Ts): Measurement Properties of a New Multidimensional Composite Tool for the Quick Assessment of the Overall Health Status in Psoriatic Arthritis.银屑病关节炎5级量表(PsA-5Ts):一种用于快速评估银屑病关节炎整体健康状况的新型多维复合工具的测量特性
J Pers Med. 2023 Jul 18;13(7):1153. doi: 10.3390/jpm13071153.
2
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.阿巴西普可降低银屑病关节炎患者滑膜调节性T细胞的表达。
Arthritis Res Ther. 2017 Jul 5;19(1):158. doi: 10.1186/s13075-017-1364-3.
3
Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study.
重要的治疗结果为患有银屑病关节炎的患者:一个多地点的定性研究。
Patient. 2017 Aug;10(4):455-462. doi: 10.1007/s40271-017-0221-4.
4
The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version.银屑病关节炎疾病影响12项问卷:触摸屏版与纸笔版的等效性、信度、效度及可行性
Ther Clin Risk Manag. 2016 Apr 21;12:631-42. doi: 10.2147/TCRM.S101619. eCollection 2016.
5
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare.在炎症性关节炎和单关节炎发作患者的达标治疗策略中,关节腔内注射抗肿瘤坏死因子α药物与皮质类固醇相比的安全性和有效性。
Int J Immunopathol Pharmacol. 2016 Jun;29(2):252-66. doi: 10.1177/0394632015593220. Epub 2015 Dec 18.
6
Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.银屑病关节炎的疾病活动度:现实世界中六种综合指数的鉴别能力与结构效度比较
Biomed Res Int. 2014;2014:528105. doi: 10.1155/2014/528105. Epub 2014 May 20.
7
The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment.银屑病和银屑病关节炎中的白细胞介素-17通路:疾病发病机制及治疗可能性
Curr Rheumatol Rep. 2014 Apr;16(4):414. doi: 10.1007/s11926-014-0414-y.
8
Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.轴性脊柱关节炎患者中的纤维肌痛:流行病学概况及对疾病活动度指标的影响
Rheumatol Int. 2014 Aug;34(8):1103-10. doi: 10.1007/s00296-014-2955-9. Epub 2014 Feb 8.
9
Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?早期银屑病关节炎的治疗方案:是否取决于疾病表型?
Curr Rheumatol Rep. 2012 Aug;14(4):334-42. doi: 10.1007/s11926-012-0265-3.